Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Modified T Cell Therapy for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 1
Omaha, Nebraska
This trial tests JCAR017, a therapy that modifies a patient's immune cells to fight cancer, in adults with difficult-to-treat non-Hodgkin's lymphoma. The study aims to find the safest and most effective way to use this therapy. JCAR017 has shown potential in treating non-Hodgkin's lymphoma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service